Sensus Healthcare Inc
NASDAQ:SRTS
| Market Cap (Intraday) | 192.53M |
| Current PE | 7.67 |
| Forward PE | 8.85 |
| 2yr Forward PE | 13.04 |
| 10-Day MA | $13.42 |
| 50-Day MA | $12.55 |
| 200-Day MA | $9.58 |
Sensus Healthcare Inc Stock, NASDAQ:SRTS
851 Broken Sound Parkway NW, Suite 215, Boca Raton, Florida 33487
United States of America
Phone: +1.561.922.5808
Number of Employees: 37
Description
Sensus Healthcare, Inc. operates as a medical device company, which provides treatments for both oncological and non-oncological skin conditions. The firm's portfolio of treatment devices includes the SRT-100, SRT-100+, and SRT-100 Vision. Its main product superficial radiation therapy (SRT), a photon x-ray low energy superficial radiotherapy system that provides patients an alternative to surgery for treating basal cell and squamous cell skin cancers, and other skin conditions, such as keloids. The company was founded by Joseph C. Sardano, Richard Golin, Kalman Fishman, and Stephen Cohen on May 7, 2010 and is headquartered in Boca Raton, FL.